Home LiteratureArticle Details
PMID: 10074148 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.

Journal of virology ·Vol. 73 ·No. 4 ·1999-04-00 ·Pages 2983-93

Sjöblom-Hallén A, Yang W, Jansson A, Rymo L

Abstract

The tumor-associated latent membrane protein 1 (LMP1) gene in the Epstein-Barr virus (EBV) genome is activated by EBV-encoded proteins and cellular factors that are part of general signal transduction pathways. As previously demonstrated, the proximal region of the LMP1 promoter regulatory sequence (LRS) contains a negative cis element with a major role in EBNA2-mediated regulation of LMP1 gene expression in B cells. Here, we show that this silencing activity overlaps with a transcriptional enhancer in an LRS sequence that contains an E-box-homologous motif. Mutation of the putative repressor binding site relieved the repression both in a promoter-proximal context and in a complete LRS context, indicating a functional role of the repressor. Gel retardation assays showed that members of the basic helix-loop-helix transcription factor family, including Max, Mad1, USF, E12, and E47, and the corepressor mSin3A bound to the E-box-containing sequence. The enhancer activity correlated with the binding of USF. Moreover, the activity of the LMP1 promoter in reporter constructs was upregulated by overexpression of USF1 and USF2a, and the transactivation was inhibited by the concurrent expression of Max and Mad1. This suggests that Max-Mad1-mediated anchorage of a multiprotein complex including mSin3A and histone deacetylases to the E-box site constitutes the basis for the repression. Removal of acetyl moieties from histones H3 and H4 should result in a chromatin structure that is inaccessible to transcription factors. Accordingly, inhibition of deacetylase activity with trichostatin A induced expression of the endogenous LMP1 gene in EBV-transformed cells.

MeSH Terms
Base Sequence Basic Helix-Loop-Helix Leucine Zipper Transcription Factors Basic-Leucine Zipper Transcription Factors Capsid/genetics Carrier Proteins Cell Cycle Proteins Chromatin/genetics,ultrastructure DNA-Binding Proteins/genetics Gene Expression Regulation, Viral Genes, Viral Genome, Viral Herpesvirus 4, Human/genetics Humans Molecular Sequence Data Nuclear Proteins/genetics Phosphoproteins/genetics Repressor Proteins/genetics Sin3 Histone Deacetylase and Corepressor Complex Transcription Factors Viral Matrix Proteins/genetics
Chemicals
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors Basic-Leucine Zipper Transcription Factors Carrier Proteins Cell Cycle Proteins Chromatin DNA-Binding Proteins EBV-associated membrane antigen, Epstein-Barr virus MAD1L1 protein, human MAX protein, human Myc associated factor X Nuclear Proteins Phosphoproteins Repressor Proteins SIN3A transcription factor Transcription Factors Viral Matrix Proteins Sin3 Histone Deacetylase and Corepressor Complex
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sjöblom-Hallén A
Department of Clinical Chemistry and Transfusion Medicine, Göteborg University, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden. [email protected]
Yang W
Jansson A
Rymo L
References (67)
67 references, click to expand
  1. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    J Virol. 1996 Sep;70(9):6020-8 PMID: 8709224
  2. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  3. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    J Gen Virol. 1995 Nov;76 ( Pt 11):2669-78 PMID: 7595374
  4. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
    EMBO J. 1994 Dec 15;13(24):6041-51 PMID: 7813442
  5. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
    Nucleic Acids Res. 1988 Sep 12;16(17):8391-410 PMID: 2843816
  6. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
    Int J Cancer. 1972 Jul 15;10(1):44-57 PMID: 4122458
  7. Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP).
    J Virol. 1998 Apr;72(4):2969-74 PMID: 9525618
  8. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Virology. 1994 Nov 1;204(2):634-41 PMID: 7941331
  9. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Cell. 1993 Jan 29;72(2):223-32 PMID: 8425219
  10. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene.
    J Virol. 1995 Apr;69(4):2633-6 PMID: 7884916
  11. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Virology. 1979 Apr 15;94(1):228-31 PMID: 220786
  12. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
    J Virol. 1998 Feb;72(2):1365-76 PMID: 9445037
  13. Myc and Max associate in vivo.
    Genes Dev. 1992 Jan;6(1):71-80 PMID: 1730411
  14. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4 PMID: 8415670
  15. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    J Gen Virol. 1987 Jun;68 ( Pt 6):1575-86 PMID: 2438376
  16. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    J Gen Virol. 1995 Nov;76 ( Pt 11):2679-92 PMID: 7595375
  17. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    EMBO J. 1995 Nov 15;14(22):5646-59 PMID: 8521822
  18. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    J Virol. 1992 Jan;66(1):122-31 PMID: 1309242
  19. Max: functional domains and interaction with c-Myc.
    Genes Dev. 1992 Jan;6(1):81-92 PMID: 1730412
  20. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    EMBO J. 1994 Dec 1;13(23):5624-32 PMID: 7988559
  21. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    J Virol. 1995 Jan;69(1):253-62 PMID: 7983717
  22. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
    Virology. 1987 Jul;159(1):161-5 PMID: 3037776
  23. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
    Cancer Res. 1968 Jul;28(7):1300-10 PMID: 4174339
  24. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins.
    Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):599-602 PMID: 1731330
  25. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms.
    J Biol Chem. 1996 Jan 19;271(3):1405-15 PMID: 8576131
  26. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    J Virol. 1997 Sep;71(9):6619-28 PMID: 9261384
  27. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  28. The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover.
    Cell Growth Differ. 1991 Dec;2(12):653-600 PMID: 1667088
  29. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7390-4 PMID: 2170976
  30. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    J Virol. 1997 Sep;71(9):6611-8 PMID: 9261383
  31. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
    EMBO J. 1994 Oct 17;13(20):4973-82 PMID: 7957063
  32. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    J Virol. 1990 Nov;64(11):5441-7 PMID: 2170681
  33. DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein-Barr virus containing the terminal repeat sequences.
    Mol Biol Med. 1983 Nov;1(4):425-45 PMID: 6094955
  34. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Science. 1991 Mar 8;251(4998):1211-7 PMID: 2006410
  35. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    J Virol. 1993 Apr;67(4):2014-25 PMID: 8445720
  36. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Cell. 1993 Jan 29;72(2):211-22 PMID: 8425218
  37. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
    Cell. 1997 May 2;89(3):349-56 PMID: 9150134
  38. Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.
    J Gen Virol. 1987 Sep;68 ( Pt 9):2407-18 PMID: 2821180
  39. Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.
    Proc Soc Exp Biol Med. 1967 Jan;124(1):107-11 PMID: 4163469
  40. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
    J Virol. 1984 Aug;51(2):411-9 PMID: 6086953
  41. Transcription factors 2: helix-loop-helix.
    Protein Profile. 1995;2(6):621-702 PMID: 7553065
  42. What's up and down with histone deacetylation and transcription?
    Cell. 1997 May 2;89(3):325-8 PMID: 9150131
  43. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  44. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.
    Virology. 1993 Jul;195(1):71-80 PMID: 8391188
  45. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
    Cell. 1995 Mar 10;80(5):767-76 PMID: 7889570
  46. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.
    J Virol. 1979 Feb;29(2):657-65 PMID: 219253
  47. A natural classification of the basic helix-loop-helix class of transcription factors.
    Proc Natl Acad Sci U S A. 1997 May 13;94(10):5172-6 PMID: 9144210
  48. Binding of myc proteins to canonical and noncanonical DNA sequences.
    Mol Cell Biol. 1993 Sep;13(9):5216-24 PMID: 8395000
  49. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
  50. Chromatin structure of Epstein-Barr virus.
    J Gen Virol. 1985 Sep;66 ( Pt 9):1931-40 PMID: 2993484
  51. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.
    Nucleic Acids Res. 1993 Nov 25;21(23):5372-6 PMID: 8265351
  52. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).
    Int J Cancer. 1977 Jan;19(1):27-33 PMID: 188769
  53. Hairy function as a DNA-binding helix-loop-helix repressor of Drosophila sensory organ formation.
    Genes Dev. 1994 Nov 15;8(22):2743-55 PMID: 7958930
  54. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.
    Curr Opin Genet Dev. 1994 Feb;4(1):102-8 PMID: 8193530
  55. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nature. 1998 May 28;393(6683):386-9 PMID: 9620804
  56. Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.
    Virology. 1994 May 1;200(2):661-7 PMID: 8178450
  57. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
    J Virol. 1989 Jul;63(7):3135-41 PMID: 2470924
  58. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    J Gen Virol. 1993 Mar;74 ( Pt 3):361-9 PMID: 8383171
  59. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002 PMID: 2479717
  60. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.
    Science. 1990 Nov 23;250(4984):1104-10 PMID: 2174572
  61. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
    J Gen Virol. 1991 Jul;72 ( Pt 7):1591-9 PMID: 1649897
  62. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein.
    Trends Microbiol. 1998 May;6(5):175-7; discussion 177-8 PMID: 9614338
  63. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.
    J Virol. 1986 Apr;58(1):233-7 PMID: 3005654
  64. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    J Virol. 1991 Dec;65(12):6826-37 PMID: 1658376
  65. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
    Science. 1995 Apr 28;268(5210):560-3 PMID: 7725102
  66. RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.
    Nucleic Acids Res. 1995 Dec 25;23(24):4939-45 PMID: 8559649
  67. The p300/CBP family: integrating signals with transcription factors and chromatin.
    Trends Cell Biol. 1997 Jun;7(6):230-6 PMID: 17708951
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-04-00
Pages
2983-93
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC104058
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]